A charity which started around a kitchen table is making a difference to people being treated for cancer. Chemotivation, ...

Proper nutrition is important to any cancer battle, but this can often become difficult because of something called "Chemo ...

The anti-parasitic drug became a household name during the COVID-19 pandemic, and it is now being embraced as an alternative ...

"Patients do not want to be shielded from difficult treatment decisions," says Associate Professor Jannicke Rabben at ...

In A Nutshell A new study found that nearly 72 percent of older adults with advanced cancer prioritized quality of life over survival, while only about 1 in 12 said living longer was their top ...

A phase 3 trial of Roche’s giredestrant in first-line breast cancer patients has missed its primary endpoint, tarnishing the record of a drug that hit the mark in adjuvant and second-line settings.

Surgeon Gareth Honeybone wants wider access to zanidatamab to treat one of the deadliest cancers.

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) ...

The alternative medicine industry is expanding rapidly, fueled in large part by the surge of health-related content on social ...

It may be best not to go off-script when it comes to breast cancer. Roughly 1 in 8 US women are expected to be diagnosed with invasive breast cancer at some point. It’s the most common cancer in women ...

Roche Holdings AG on Monday shared results from the phase 3 persevERA Breast Cancer study of giredestrant combined with palbociclib in advanced cancer patients. Trial Misses Primary Goal The trial ...